Soft–hard-donor-combined ligands
are a type of promising
extractant for actinide and lanthanide separation. In this work, the
effects of counteranions (Cl–, NO3
–, and ClO4
–) on the extraction
and complexation behaviors of a recently reported tetradentate phenanthroline-derived
phosphonate (POPhen) ligand toward lanthanides were thoroughly investigated
using solvent extraction, NMR titration, UV–vis titration,
and single-crystal X-ray diffraction measurements. It is found that
C4-POPhen showed excellent extraction and selectivity toward heavy
lanthanides [Lu(III)] compared to light lanthanides, particularly
with the counterion of ClO4
– and at low
acidity. NMR titration studies demonstrated that both 1:1 and 1:2
Lu(III)/C4-POPhen complexes were formed in a CD3OD solution
with all three counteranions and the 1:2 species was easier to form
in a complexation of C4-POPhen with Lu(ClO4)3 under the same conditions. Furthermore, the stability constants
of Nd(III) complexation with C4-POPhen in the counteranions of Cl–, NO3
–, and ClO4
– systems were determined through UV–vis
titration, and a much larger value of log β of complexes was
found in the ClO4
– system, which was
in good agreement with the results of solvent extraction. In addition,
the structures of C2-POPhen complexation with Ln(NO3)3/Ln(ClO4)3 in the solid state were clearly
unraveled by the single-crystal X-ray diffraction technique. This
work demonstrated that the solvent extraction and complexation mechanisms
of POPhen ligands with Ln(III) were significantly affected by the
counteranions from both the solution and solid-state aspects, which
might shed light on the lanthanide/actinide separation.
N,O-hybrid
diamide ligands with N-heterocyclic skeletons are one
of the promising extractants for the selective separation of actinides
over lanthanides in a highly acidic HNO3 solution. In this
work, three hard–soft donor mixed diamide ligands, pyridine-2,6-diylbis(pyrrolidin-1-ylmethanone)
(Pyr-PyDA), 2,2′-bipyridine-6,6′-diylbis(pyr-rolidine-1-ylmethanone)
(Pyr-BPyDA), and (1,10-phenanthroline-2,9-diyl)bis(pyrrolidin-1-ylmethanone)
(Pyr-DAPhen), were synthesized and used to probe the influence of
N-heterocyclic cores on the complexation and extraction behaviors
with trivalent lanthanides and actinides. 1H NMR titration
experiments demonstrated that 1:1 metal-to-ligand complexes were mainly
formed between the three ligands and lanthanides, but 1:2 type complexes
were also formed between tridentate Pyr-PyDA and Lu(III). The stability
constants (log β) of these three ligands with two typical lanthanides,
Nd(III) and Eu(III), were determined through spectrophotometric titration.
It is found that Pyr-DAPhen formed the most stable complexes, while
Pyr-PyDA formed the most unstable complexes with lanthanides, which
coincided well with the following solvent extraction results. The
solid-state structures of 1:1 type complexes of these three ligands
with La(III), Nd(III), and Er(III) in nitrate media were identified
by a single-crystal X-ray diffraction technique. Nd(III) and Er(III)
were 10-coordinated with Pyr-PyDA, Pyr-BPyDA, and Pyr-DAPhen via one
ligand molecule and three nitrate ions. La(III), because of its larger
ionic radius, was 11-coordinated with Pyr-DAPhen through one ligand
molecule, three nitrate ions, and one methanol molecule. Solvent extraction
experiments showed that the preorganized phenanthroline-derived Pyr-DAPhen
had the best extraction performance for trivalent actinide among the
three ligands tested. This work provides some experimental insights
into the design of more efficient ligands for trivalent actinide separation
by adjusting the N-heterocyclic cores.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.